At Johns Hopkins in Baltimore, cardiologists are road-testing a patient-specific "digital twin" of a diseased heart, a computer model used to plan and guide catheter ablation for a dangerous rhythm called ventricular tachycardia. In this early trial, clinicians first ran virtual ablations on the twin, then imported the model's target map into the real procedure. The idea is to cut down hours of intraoperative searching, spare as much healthy heart tissue as possible, and, with any luck, reduce the odds that patients will need to come back for repeat procedures.
Researchers with Johns Hopkins' Alliance for Cardiovascular Diagnostic and Treatment Innovation built each virtual heart from advanced MRI and other patient data, then ran simulations to pinpoint the electrical circuits driving the arrhythmia, according to Johns Hopkins Medicine. To make the whole thing usable in a real clinic schedule, the team also developed an AI tool called DIMON that cuts computation times from hours to seconds, so simulations actually fit into the workflow. Johns Hopkins reports that the system lets cardiologists "treat the twin before the patient" and port the twin's ablation targets directly into the mapping system used in the lab.
How the twin guides doctors
Investigators start by creating a 3-D model from late-gadolinium cardiac MRI, then run rapid pacing protocols inside that virtual heart to induce and map digital ventricular tachycardia circuits. This in silico mapping predicts where ablation lesions should go to shut down the arrhythmia, and earlier peer-reviewed work has shown that digital twins often match the invasively mapped circuits that are recorded during real procedures. A combined clinical and modeling study published in Circulation: Arrhythmia and Electrophysiology lays out the method in detail and reports on its predictive performance.
Early clinical results
In a small, FDA-allowed feasibility test at Hopkins, the team used digital twin targets to guide ablation in 10 patients and then followed them for more than a year. Eight patients had no recurrent arrhythmias, and two had only a single brief episode during the normal healing period, an outcome that investigators said stacks up well against typical success rates. Most patients were able to discontinue anti-arrhythmic drugs, as reported by The Associated Press. Lead author Dr. Jonathan Chrispin said the strategy could make procedures shorter and safer, while Natalia Trayanova summed up the philosophy: "We treat the twin before we treat the patient."
What's next for the technology
Doctors and engineers are quick to point out that this is early-stage work. The study was small and built to prove the approach is feasible, not to show it beats standard mapping approaches. Johns Hopkins teams are lining up larger, multi-center trials to test how reproducible the results are and have started adapting the workflow for atrial fibrillation, according to Johns Hopkins reporting. If bigger studies confirm a real benefit, digital twins could reshape how electrophysiologists plan and carry out complex ablations.
What this means for patients
Ventricular tachycardia and other shockable rhythms remain a major driver of sudden cardiac arrest in the United States, with hundreds of thousands of out-of-hospital cardiac arrests every year, according to the American Heart Association. Patients in the Baltimore region could eventually see more precise ablation options at centers like Johns Hopkins, although wider use will hinge on randomized trials and regulatory clearances beyond the current investigational phase. For now, the Hopkins experience stands as an early hint that engineering and cardiology together might make ablation smarter instead of harsher.
